Skip to main content

Board of Trustees - New Jersey

The New Jersey Board of Trustees is comprised of distinguished individuals dedicated to LLS's mission to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

The New Jersey Board of Trustees is comprised of distinguished individuals dedicated to LLS's mission to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.  
  • Lynda Bennett, Lowenstein Sandler LLP
  • Mike Capone, Qlik
  • Ivy Charmatz, Mercury Public Affairs 
  • Sarah Cirelli, Grassi (Board Volunteer Development Chair)
  • Joe Cupoli, P&A Auto Parts (Board Vice Chair)
  • John Hyland, Private Advisor Group
  • Dr. Matt Matasar, Rutgers Cancer Institute
  • Jennifer Matos PhD, Fingerpaint 
  • Swati Navani, Pfizer
  • Kristen Pappas, Onyx Equities
  • Eduardo Schur, EY
  • Mike Shevlin, Microsoft
  • Winselow Tucker, Loxo Oncology at Lilly (Board Chair)
  • James Wishbow, Wishbow Construction
  • Alexis Wolfson, Conner Strong & Buckelew